Maze Therapeutics (MAZE) Cash from Investing Activities (2024 - 2026)

Maze Therapeutics' Cash from Investing Activities history spans 3 years, with the latest figure at $6.3 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 2198.66% to $6.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$164.4 million, a 13986.38% decrease, with the full-year FY2025 number at -$171.0 million, down 14805.14% from a year prior.
  • Cash from Investing Activities hit $6.3 million in Q1 2026 for Maze Therapeutics, up from -$103.4 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for MAZE hit a ceiling of $6.3 million in Q1 2026 and a floor of -$103.4 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$18.4 million across 3 years, with a median of -$299000.0 in 2025.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 64834.95% in 2025 and later skyrocketed 2198.66% in 2026.
  • Tracing MAZE's Cash from Investing Activities over 3 years: stood at -$605000.0 in 2024, then plummeted by 16988.76% to -$103.4 million in 2025, then surged by 106.07% to $6.3 million in 2026.
  • Business Quant data shows Cash from Investing Activities for MAZE at $6.3 million in Q1 2026, -$103.4 million in Q4 2025, and -$66.9 million in Q3 2025.